Silexion Therapeutics
$1.28
25
+$0.07+5.79% Today
Statistics
Day High
1.26
Day Low
1.18
52W High
15.6
52W Low
1.16
Volume
18,710
Avg. Volume
39,814
Mkt Cap
4M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19MayExpected
Expected EPS
-1.29
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-32.89MNet Income
Analyst Ratings
$6.00Average Price Target
The highest estimate is 6.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SLXN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Show more...
CEO
Mr. Ilan Hadar M.B.A.
Employees
11
Country
US
ISIN
KYG1281K1307
Listings
0 Comments
Share your thoughts
FAQ
What is Silexion Therapeutics stock price today?▼
The current price of SLXN is $1.28 USD — it has increased by +5.79% in the past 24 hours. Watch Silexion Therapeutics stock price performance more closely on the chart.
What is Silexion Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Silexion Therapeutics stocks are traded under the ticker SLXN.
Is Silexion Therapeutics stock price growing?▼
SLXN stock has risen by +10.34% compared to the previous week, the month change is a -26.01% fall, over the last year Silexion Therapeutics has showed a -90.11% decrease.
What is Silexion Therapeutics market cap?▼
Today Silexion Therapeutics has the market capitalization of 4M
When is the next Silexion Therapeutics earnings date?▼
Silexion Therapeutics is going to release the next earnings report on May 19, 2026.
What were Silexion Therapeutics earnings last quarter?▼
SLXN earnings for the last quarter are -2.39 USD per share, whereas the estimation was -1.12 USD resulting in a -112.95% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Silexion Therapeutics revenue for the last year?▼
Silexion Therapeutics revenue for the last year amounts to 0 USD.
What is Silexion Therapeutics net income for the last year?▼
SLXN net income for the last year is -32.89M USD.
How many employees does Silexion Therapeutics have?▼
As of April 06, 2026, the company has 11 employees.
In which sector is Silexion Therapeutics located?▼
Silexion Therapeutics operates in the Health Care sector.
When did Silexion Therapeutics complete a stock split?▼
The last stock split for Silexion Therapeutics was on July 29, 2025 with a ratio of 1:15.
Where is Silexion Therapeutics headquartered?▼
Silexion Therapeutics is headquartered in Jerusalem, US.